JPRN-UMIN000047270已完成未知
Effect of high dose SGLT-2 inhibitor on fatty liver - Effect of high dose SGLT-2 inhibitor on fatty liver
Konuma Internal medicine Gastroenterology Clinic directer0 个研究点目标入组 20 人开始时间: 2022年3月23日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who have completed less than 6 months of high-dose SGLT-2 inhibitor therapy
研究者
相似试验
已完成
不适用
Improving fatty liver by SGLT-2 inhibitorType 2 diabetes mellitus with hepatic steatosisJPRN-jRCTs031200093Tsuchiya Kyoichiro1
招募中
Unknown
Effect of SGLT2 inhibitor to epicardial adipose tissue thickness in patient with heart failure with left ventricular ejection fraction over 40% and increased epicardial adipose tissue thicknessKCT0008535Kangbuk Samsung Medical Center30
已完成
不适用
Efficacy of SGLT2 inhibitor for nonalcoholic fatty liver disease: a randomized controlled trialonalcoholic fatty liver diseaseJPRN-UMIN000026057Tohoku university10
已完成
不适用
Effect of SGLT-2 inhibitors on Hepatic Steatosis and Fibrosis Estimated by using Fibroscan with Type 2 Diabetes Suffering from Non-alcoholic Fatty Liver DiseaseType 2 Diabetes Suffering from Non-alcoholic Fatty Liver DiseaseJPRN-UMIN000022155Dokkyo Medical University60
已完成
1 期
SGLT2 Inhibitor Effects on Inflammation and Heart Disease in Obesity PilotPre-diabetesObesityNCT04907214Vanderbilt University Medical Center29